Date: Friday 27 September 2013
Time: 12:40 - 14:20
Location: Exhibition area
Chair: Kaspars Snippe

Panel review of half of the best posters:

  • LTP46: Combining a low rectal cancer mri staging system with clinical assessment and optimal patient management can significantly reduce tumour involvement at the circumferential resection margin: experience from the MERCURY II Low Rectal Cancer Study - Nick Battersby (Pelican Cancer Foundation, UK)
  • LTP48: Long term outcomes of conversion in laparoscopic colorectal surgery: A single institution experience - Rena Dharmawan (Department of Colorectal Surgery, Singapore General Hospital, Singapore)
  • LTP49: Somatic c.34G>T Kras mutation: a new screening test for MUTYH-associated polyposis? - Jeremie Lefevre (Hopital Saint-Antoine, France)
  • LTP50: User defined opinions of outcome measures for Colorectal Cancer Multidisciplinary team meetings - Sujay Shah (Imperial College, UK and Barnet Hospital, UK)
  • LTP51: Surgical resection is a independent prognostic factor in Krukenberg tumors of colorectal origin - Jaekyun Ju (Chonnam National University Hospital, Republic of Korea)
  • LTP52: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis from colorectal cancer - Young Jin Kim (Chonnam National University Hospital, Republic of Korea)
  • LTP53: Development of local and distant recurrence following complete pathological response of resected rectal cancer is rare - Franscois Runau (University Hospitals of Leicester, UK)
  • LTP54: The extent and completeness of mesorectal excision evaluated by postoperative MRI - Peter Bondeven (Aarhus University Hospital, Department of Surgery and Department of Diagnostic Imaging, Denmark)
  • LTP55: Colonic stenting in acute large bowel obstruction:15 year experience in a single institution - Pawan Mathur (Barnet and Chase Farm NHS Trust, UK)
  • LTP57: Early results of colorectal cancer screening programs: should we treat also colon cancer in referral centers? - Francesco Bianco (National Cancer Institute G. Pascale, Italy)
  • LTP58: Distal location and good response to chemoradiotherapy in locally advanced rectal cancer - Pedro Moreira (Department of Surgery-Hospital de Santo António, Portugal)
  • LTP59: The clinical importance of large and small-vessel EMVI in rectal cancer - Manish Chand (Royal Marsden Hospital, UK and Imperial College, UK)
  • LTP60: Closing the loop: delays and difficulties restorating bowel continuity following anterior resection - Simon Fallis (Queen Elizabeth Hospital, UK)
  • LTP61: Surgical management of anastomotic leakage after curative resection for colonic cancer: a nationwide observational study - Peter-Martin Krarup (Dept. of Surgery, Bispebjerg Hospital, Denmark)
  • LTP62: Systematic review of neutrophil to lymphocyte ratio (NLR) as a prognostic predictor of outcome of surgery in primary colorectal adenocarcinoma - Thomas Clarke (University of Exeter School of Medicine, UK)
  • LTP63: A systematic review of anal squamous cell carcinoma in inflammatory bowel disease - Alistair Slesser (Imperial College, UK and The Royal Marsden Hospital, UK)
  • LTP64: Should colon assessment for cancer be undertaken in normocytic anaemia? - Daniel Thomas (Queen Mary Hospital, UK)
  • LTP65: Comparison of radiological and pathological staging in colon cancer - Andrew McAvoy (Southport District General Hospital, UK)
  • LTP66: Is there an age limit for standard rectal cancer treatment? - Tore Stornes (St. Olavs Hospital, Norway and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Norway)
  • LTP67: Oncological outcomes following anastomotic leaks in rectal cancer surgery (James Hernon (Norfolk and Norwich University Hospital NHS, UK)
  • LTP68: Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore - Min Hoe Chew (Singapore General Hospital, Singapore)
  • LTP69: Is there a difference between a man and his mouse? How patient-derived xenografts accurately reflect primary colorectal adenocarcinoma in order to personalise chemobiological therapy - Gaitri Sadadcharam (Department of Academic Surgery, Cork University Hospital, Ireland)
  • LTP70: A temporary loop ileostomy may reduce the estimated glomerular filtration rate - Bodil Gessler (Sahlgrenska University Hospital, Sweden and SSORG - Scandinavian Surgical Outcomes Research Group, Sweden)
  • LTP71: It’s not just an infection: wound dehiscence after APR for rectal cancer is associated with decreased survival - Liliana Bordeianou (Massachusetts General Hospital, USA)
  • LTP72: Transglutaminase-2 as a novel marker for prediction of chemosensitivity in stage ii colorectal cancer - Im-kyung Kim (Yonsei University College of Medicine, Republic of Korea)
  • LTP73: Lymph nodes status in patients with rectal cancer undergoing neoadjuvant chemo-radiation with complete / near complete pathological response. winds of changes? - Haya Shwaartz (Department of Surgery, Sheba Medical Center, Israel and Sackler School of Medicine, Tel Aviv University, Israel)
  • LTP74: Anterior perineal plane for ultra-low anterior resection of the rectum (the appear technique) clinical, functional & oncological medium term outcomes - Alexander Hotouras (Academic Surgical Unit, National Centre for Bowel Research and Surgical Innovation, Barts Health NHS Trust, UK)
  • LTP75: The impact of BMI (body mass index) on colorectal cancer related tumor markers (CEA: Carcinoembryonic antigen, CA19-9: Carbohydrate antigen 19-9) - Ryo Seishima (Keio University School of Medicine, Department of Surgery, Japan)
  • LTP76: Extended intersphincteric resection for ultra low rectal cancer - who will benefit? - Dmitry Pikunov (State Research Center of Coloproctology, Russia)
  • LTP77: Transanal minimally invasive microsurgery (TAMIS): An initial single institute experience - Naomi Fearon (Tallaght Hospital, Ireland)
  • LTP78: Surgery for small bowel neuroendocrine tumors: long term results in 73 consecutive patients - Marleny Figueiredo (Beaujon Hospital, France)
  • LTP79: Is there any limit for transanal endoscopic microsurgery (TEM) ? A comparative study between standard and borderline indications in 133 patients - Arnaud Saget (Beaujon Hospital, France)
  • LTP81: Screening the anal dysplasia in hiv-positive patients: how efficient is high-resolution anoscopy? - Laurent Siproudhis (CHU Pontchaillou, France and Université de Rennes 1, France)
  • LTP82: Re-referral following primary rubber band haemorrhoidal ligation therapy.
  • Talal Altayeb (Academic Surgical Unit, UK)
  • LTP83: Acute sacral nerve stimulation affects sensory but not motor neurones of the anal canal in an animal model - Liam Devane (University College Dublin, Ireland)
  • LTP84: Crohn's and idiopathic fistula tracks are positive for endotoxins - Nuha Yassin (St Mark's Hospital, UK and APRG, UK)
  • LTP85: Stapler haemorrhoidopexy alone versus stapler haemorrhoidopexy and mucopexy for grade III internal hemorrhoids: a prospective observational study - Ashwin Porwal (Healing Hand Clinic, India and Jehangir Hospital, India)
  • LTP86: A comparison of outpatient rigid sigmoidoscopy versus flexible sigmoidoscopy; does outpatient rigid sigmoidoscopy still have a role? - Simon Gonsalves (Calderdale and Huddersfield NHS Trust, UK)
  • LTP87: Anocutaneous advancement anal flap in the treatment of chronic anal fissure: a long term follow up (Alessandro Stazi (Cdc Madonna delle Grazie, Italy)
  • LTP88: Surgical anatomy of perirectal and presacral fascias and spaces revisited - Dragomir Dardanov (2nd Department of Surgery, 5th City Hospital, Bulgaria and Department of Anatomy and Histology, Medical Faculty, Sofia University 'St. Kliment Ohridski', Bulgaria)
  • LTP89: Randomized single blind clinical trial of intradermal methylene blue on pain reduction after open diathermy haemorrhoidectomy - Hsien Lin Sim (Khoo Teck Puat Hospital, Singapore)
  • LTP90: Efficacy of THD Doppler procedure in treating hemorrhoidal symptoms - Carlo Ratto (Catholic University, Italy)
  • LTP91: Ligation of inter sphincteric fistula tract (LIFT) in the treatment of complex anal fistulas compared to rectal flap advancement (ARAF) - Alessandro Garcea (Hospital de Torrevieja, Spain)
  • LTP92: Gore Bio-A plug: 12 months results in anal fistula healing - Alexander Herold (End- und Dickdarm-Zentrum, Germany)
  • LTP93: Ligation of the intersphincteric tract (LIFT): a minimal invasive procedure for complex anal fistula. Two years of results of a prospective multicentric study - Pierpaolo Sileri (University of Rome; 'Tor Vergata', Italy)
  • LTP94: Cortical evoked potentials in response to rapid balloon distension in the anal canal - Susanne Haas (Aarhus University Hospital, Surgical department P, Denmark)
ESCP Affiliates